Answers are grounded in this paper and cite their sources.
This nationwide cohort study confirms the clinical value of the wearable cardioverter-defibrillator for patients at high risk of sudden cardiac death outside the US healthcare system.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wäßnig et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: